DeepCardio

DeepCardio

Private
IncheonHealthcare & Life Scienceshttps://deepcardio.com

Last Round

Series B

Feb 15, 2026

Total Funding Raised

$33.4M

Momentum Score

25 /100

Company Overview

DeepCardio is a healthcare technology company that provides an AI-based solution to analyze ECG signals for the early prediction and detection of heart diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware + Subscription

AI Layer

Application

Keywords

atrial fibrillation detectionAI ECG analysisAFib detectionpredictive diagnosticsheart disease detectionsoftware-as-a-medical-deviceSaMDclinical decision supportmedical AIcardiac diagnosticsparoxysmal atrial fibrillationejection fraction analysiscoronary artery disease detectioncardiac ageGE Healthcare integration

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DeepCardio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

DeepCardio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 15, 2026
Series AFeb 17, 2022

DeepCardio Investors

Notable investors and investment history

InvestorRounds
DAYLI PartnersSeries A
SoftBank GroupSeries A
Enlight VenturesSeries B
QUAD VenturesSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 15, 2026

    $2.1M round raised

  • Feb 15, 2026

    Products used in over 20 major hospitals in Korea.

DeepCardio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DeepCardio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DeepCardio's valuation, stock price, and market status.

Firmographic Details

HeadquartersIncheon
Employee Range7
Year Founded2020
Last FundingFeb 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.